PR inside: DEA's Marijuana Rescheduling Administrative Law Sham: Unaccountable ...
(PR-inside.com) Whether it involves the DEA's much-publicized marijuana rescheduling efforts or MMJ BioPharma's lawful pursuit of a federal registration to conduct FDA-authorized clinical trials, one immovable obstacle remains: the DEA's constitutionally defective administrative adjudication system. Presided over by Chief Administrative Law Judge John J. Mulrooney II, this internal tribunal-often referred to as a "kangaroo court"-violates foundational principles of due process and Article II of the U.S. Constitution.
WASHINGTON, DC / ACCESS Newswire / July 23, 2025 / As the Drug Enforcement Administration (DEA) continues to obstruct pharmaceutical cannabis research, a far deeper scandal is unfolding beneath the surface-the DEA's administrative court system ..
https://reports.pr-inside.com/dea-s-mar ... 121875.htm
Copyright PR-Inside.com 2025